WallStreetZenWallStreetZen

NASDAQ: ADXN
Addex Therapeutics Ltd Stock Ownership - Who owns Addex Therapeutics?

Insider buying vs selling

Have Addex Therapeutics Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ADXN insiders and whales buy or sell their stock.

ADXN Shareholders

What type of owners hold Addex Therapeutics Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Adar1 Capital Management LLC0.00%390$3.11kInstitution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

ADXN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADXN0.00%0.00%
CYCN9.83%90.17%Net Selling
CVKD10.60%46.72%Net Buying
ABVC1.20%98.80%
MBRX4.61%95.39%Net BuyingNet Selling

Addex Therapeutics Stock Ownership FAQ

Who owns Addex Therapeutics?

Addex Therapeutics (NASDAQ: ADXN) is owned by 0.00% institutional shareholders, 0.00% Addex Therapeutics insiders, and 100.00% retail investors. Adar1 Capital Management LLC is the largest individual Addex Therapeutics shareholder, owning 390.00 shares representing 0.00% of the company. Adar1 Capital Management LLC's Addex Therapeutics shares are currently valued at $3.00k.

If you're new to stock investing, here's how to buy Addex Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.